Sanofi Reports the P-II Study Data of Frexalimab for the Treatment of Multiple Sclerosis
Read More: Sanofi
AstraZeneca Reports the EMA’s Acceptance of MAA for Sipavibart Under Accelerated Assessment to Prevent COVID-19
Read More: AstraZeneca
Ipsen Reports Collaboration Expansion with Exelixis to Develop Cabometyx for Treating Neuroendocrine Tumors
Read More: Ipsen & Exelixis
HOOKIPA Reports the First Patient Dosing in P-Ib Study of HB-500 to Treat HIV
Read More: HOOKIPA
Roche Reports P-II/III (SKYSCRAPER-06) Trial Data of Tiragolumab to Treat Non-Squamous Non-Small Cell Lung Cancer
Read More: Roche
Zhejiang Doer Biologics Concludes Patient Recruitment in P-Ib/IIa Study of DR10624 Among Obese Individuals
Read More: Zhejiang Doer Biologics
Roche Reports the CHMP’s Positive Opinion of Vabysmo for Retinal Vein Occlusion (RVO)
Read More: Roche
AbbVie’s Tepkinly (Epcoritamab) Gains the CHMP’s Positive Opinion to Treat R/R Follicular Lymphoma
Read More: AbbVie
AstraZeneca’s Lynparza Plus Imfinzi Receives the CHMP’s Positive Opinion for Treating Endometrial Cancer
Read More: AstraZeneca
Eli Lilly Reports the US FDA’s Approval of Kisunla (donanemab-azbt) to Treat Early Symptomatic Alzheimer’s Disease
Read More: Eli Lilly
Regeneron and Sanofi Report the EC’s Approval of Dupixent to Treat Chronic Obstructive Pulmonary Disease (COPD)
Read More: Regeneron & Sanofi
Johnson & Johnson’s Sirturo Gains the US FDA & EC’s Approval to Treat Pulmonary Tuberculosis
Read More: Johnson & Johnson
HUTCHMED Reports the NMPA’s NDA Acceptance of Tazemetostat for Treating Follicular Lymphoma
Read More: HUTCHMED
Full-Life Technologies’ 225Ac-FL-020 Gains the US FDA’s Fast Track Designation to Treat Metastatic Castration-Resistant Prostate Cancer
Read More: Full-Life Technologies
Medigene Receives Chinese Patent for MDG1015 to Treat Various Solid Tumors
Read More: Medigene
Roche’s Vabysmo Prefilled Syringe Receives the US FDA’s Approval for Vision Loss
Read More: Roche
AstraZeneca’s Tagrisso Plus Chemotherapy Receives the EC’s Approval to Treat EGFR-Mutated Advanced Lung Cancer
Read More: AstraZeneca
Eleva’s CPV-104 Gains EC’s Orphan Drug Designation to Treat C3 Glomerulopathy (C3G)
Read More: Eleva
Biostar Pharma Reports the US FDA’s IND Clearance for P-II Trial of Utidelone to Treat Breast Cancer Brain Metastasis
Read More: Biostar Pharma
Ubix Therapeutics Collaborates with Yuhan to Develop UBX-103 for Treating Metastatic Castration Resistant Prostate Cancer
Read More: Ubix Therapeutics & Yuhan
Radionetics Oncology and Eli Lilly Collaborate to Develop Small Molecule Radiopharmaceuticals
Read More: Radionetics & Eli Lilly
GSK and CureVac Report Restructuring of their Partnership
Read More: GSK & CureVac
Ascentage Pharma Obtains an Option Payment of $100M from Takeda
Read More: Ascentage & Takeda
Pendopharm Collaborates with Ascendis Pharma to Commercialize TransCon PTH for Treating Hypoparathyroidism in Canada
Read More: Pendopharm & Ascendis Pharma
Samsung Bioepis Reports the US FDA’s Approval of Pyzchiva (Biosimilar, Stelara)
Read More: Samsung Bioepis
Kashiv BioSciences Partners with Amneal Pharmaceuticals to Commercialize ADL018 (Biosimilar, Xolair)
Read More: Kashiv BioSciences & Amneal Pharmaceuticals
Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)
Read More: Alvotech
Formycon and Klinge Biopharma Reports the US FDA’s Approval of Ahzantive (Biosimilar, Eylea)
Read More: Formycon & Klinge Biopharma
Tanvex BioPharma Reports the US FDA’s Approval of Nypozi (Biosimilar, Neupogen)
Read More: Tanvex
Can-Fite Reports Data from its Partner Vetbiolix’s Clinical Study of Piclidenoson in Dogs with Osteoarthritis
Read More: Can-Fite
Pentixapharm Reports the Acquisition of Glycotope’s Target Discovery Business
Read More: Pentixapharm & Glycotope
Quest Diagnostics Reports the Acquisition of LifeLabs from OMERS for an Aggregate of ~$985M
Read More: Quest Diagnostics
Related Post:
